Cancer stem cells (CSCs) are unique subpopulations that have the capacity to drive malignant progression with renewal abilities. Recently the role of some of CSCs in gastric adenocarcinoma has been studied. This study was performed in order to evaluate CD44 and CD133 expressions by immunohistochemistry in 95 primary gastric adenocarcinoma and their relation to clinical and pathological parameters of these tumors. There was a significant correlation between CD44 expression and cancer subtype (intestinal), tumor size (4-8 cm), depth of invasion, no lymphatic/vascular invasion and moderate differentiation. There was a significant correlation between CD133 expression and patient's age (> 65 years), cancer subtype (intestinal), tumor size (4-8 cm), depth of invasion and moderate differentiation. CSC markers like CD 44 and CD133 had high expression in primary gastric adenocarcinoma and had some relations to clinical and pathological parameters of tumors. 
treatment of cancer unsuccessful (10) . To identify the gastric cancer cells, several studies have been conducted on some cell surface markers.
CD44 is a homing cell adhesion molecule, a cell surface glycoprotein for hyaluronic acid. This marker is expressed on the surface of red blood cells and platelets and they have been known as lymphocytic homing receptors. CD44 plays an important role in adhesion to the extracellular matrix and matrix functions, such as degeneration, proliferation and cell survival (2, 8, 10, 11) . CD133 
Materials and Methods

Patients
This research is a case-control study. The Table 2 .
Results
In
Expression of this stem cell marker was associated to intestinal type of gastric cancer, tumor size less than 8 cm (4-8cm), serous invasion without lymphatic and vascular invasion, and had significant relationship with moderately differentiated tumors as 72.5 % of the specimens were positive for this marker (Table-2) .
Distribution of CD133 expression in tumor and non-tumor samples based on age, size, type and invasion of tumor was fully described in Table   3 . As it stands to reason, CD133 expression showed positive correlation with age over 65 years, intestinal type gastric cancer, size 4 to 8 cm, moderately differentiated tumor and serous involvement.
Discussion
The annual incidence of gastric cancer is 2 % of all new cancers in the United States and it is also common in many other countries, particularly in East Asia and South America (13). Rocco et al. 
In another study, Philipilidis et al. claimed that
Helicobacter pylori and stem cells signaling may be 
CD44
CD133
Tumor cases of stomach cancer and demonstrated that the incidence of CD44 was 11.4% for s-isomer, but they did not find the V6 isomer (26) . Yamagachi et al. in a study of 95 cases of gastric carcinoma reported that the expression of CD44 v6 was 47.3% and perineural invasion as in our study (26) . Basically, studies related to the incidence and prognostic significance of CD133 in gastric cancer were limited and inadequate. Thus in this study, intentionally CD133 was examined and it was shown that it might be related to tumor size, depth and histologic grade (1), which correlated with previous reports concerning the role of CD133 in colorectal cancer (32, 33) . Lee H et al. also reported about 23% expression of CD133 in gastric cancer which was significantly related to serous involvement, venous invasion and well to moderate differentiation in intestinal type gastric cancer.
They also reported that 5-year survival rate in patients with CD133 expression was worse than in negative patients (17). In our study, the expression of CD133 in tumor samples was 49.5%. It was also positive in 17 (31.6%) non-tumoral tissues. This marker's expression was higher in participants over
